Gamer.Site Web Search

Search results

1. Results From The WOW.Com Content Network

2. FDA approves Alzheimer’s treatment that has been shown to ...

   www.aol.com/news/fda-approves-alzheimer...

   July 2, 2024 at 2:28 PM. The Food and Drug Administration approved a new Alzheimer’s drug from Eli Lilly that has been shown in clinical trials to modestly slow a decline in memory and thinking ...

3. Dopamine treatment destroys beta-amyloid plaques in ... - AOL

   www.aol.com/dopamine-treatment-destroys-beta...

   Researchers say the hormone dopamine may be used as a treatment for Alzheimer's disease as it stimulates the production of an enzyme known to break down beta-amyloid via a mouse model.

4. Alzheimer's disease - Wikipedia

   en.wikipedia.org/wiki/Alzheimer's_disease

   Alois Alzheimer. Alzheimer's disease ( AD) is a neurodegenerative disease that usually starts slowly and progressively worsens, [ 2] and is the cause of 60–70% of cases of dementia. [ 2][ 15] The most common early symptom is difficulty in remembering recent events. [ 1] As the disease advances, symptoms can include problems with language ...

5. FDA approves donanemab, Eli Lilly’s treatment for early ...

   www.aol.com/fda-approves-donanemab-eli-lilly...

   Donanemab, made by Indianapolis-based Eli Lilly, works by helping the body remove amyloid plaque buildup in the brain, a hallmark of Alzheimer’s disease. Lilly said it will be sold under the ...

6. Psychological therapies for dementia - Wikipedia

   en.wikipedia.org/wiki/Psychological_therapies...

   Psychological therapies which are considered as potential treatments for dementia include music therapy, [5] reminiscence therapy, [6] cognitive reframing for caretakers, [7] validation therapy, [8] and mental exercise. [9] Interventions may be used in conjunction with pharmaceutical treatment and can be classified within behavior, emotion ...

7. Aducanumab - Wikipedia

   en.wikipedia.org/wiki/Aducanumab

   Aducanumab is a monoclonal IgG1 antibody that binds to the amyloid beta protein at amino acids 3–7, which is posited to result in slowing the progression of Alzheimer's disease. [ 5] The mechanism is based on the amyloid hypothesis, which posits that amyloid proteins cause Alzheimer's disease, hence removing amyloid should slow the ...